Delivery Order SPE2DB25D3021-SPE2DB25FQYRC

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,632.08, is for the delivery of 1 mg/0.5 ml pens of the medication WEGOVY. The order has a firm fixed price and an ultimate completion date of November 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a $1,375.97 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.25 mg/0.5 ml pens of the drug WEGOVY. The contract has an ultimate completion date of May 20, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. The company holds a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 0.5 mg/0.5 ml pen. The delivery order has a ceiling value of $1,638.00 and a period of performance through May 1, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.50, is for the delivery of the drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed price pricing type and a period of performance ending on March 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1.7 mg/0.75 ml pens of the drug WEGOVY, with a total ceiling value of $1,261.80 and a period of performance through May 28, 2025. The award is not set aside and represents part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, with a ceiling value of $4,914.00 and a period of performance through May 1, 2025. The contract is a firm fixed price, non-set-aside delivery order. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,156.97 contract is for the supply of the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, with a period of performance through February 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the medication WEGOVY 0.5 mg/0.5 ml pen. The contract has a ceiling value of $8,190.00 and a period of performance through April 17, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $8,435.89 and a period of performance through April 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a firm-fixed price of $1,228.50 and a completion date of May 15, 2025. The contract is not set aside and is awarded as part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB25D3021
    Indefinite Delivery Contract
  • SPE2DB25D3021-SPE2DB25FQYRC
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $3,323.83, is for the delivery of 0.25 mg/0.5 ml pens of the medication WEGOVY. The contract is a firm fixed-price delivery order with a period of performance through June 6, 2025. This order is not set aside for any specific business type.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/4/25, 9:52 AM